As explained in the Kaiser Family Foundations (KFF) analysis published on November 26, 2025, this $274 figure is the price Medicare will pay to manufacturers, not the patient copay
References Dao MC, Everard A, Aron-Wisnewsky J, et al
Appropriate candidates for exploratory GLP-1 treatment with attention to mood/attention benefits typically have weight-related comorbidities, adequate psychiatric stability on current regimens, and realistic expectations about limited evidence
Table of Contents Understanding Wegovy and HCG: How Each Works for Weight Loss Can You Take Wegovy and HCG Together
Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: a randomized clinical trial
Funky Monkey Stuck in a funk